Weaning difficult-to-wean chronic obstructive pulmonary disease patients: A pilot study comparing initial hemodynamic effects of levosimendan and dobutamine

Journal of Critical Care

Volumn 26, Issue 1, 2011, Pages 15-21

  Ouanes Besbes, Lamia ^a   Ouanes, Islem ^a   Dachraoui, Fahmi ^a   Dimassi, Saoussen ^a   Mebazaa, Alexandre ^b   Abroug, Fekri ^a  

^a FATTOUMA BOURGUIBA UNIVERSITY HOSPITAL   (Tunisia)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

COPD; Dobutamine; Heart failure; Levosimendan; Mechanical ventilation; Weaning

Indexed keywords

DOBUTAMINE; LEVOSIMENDAN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DRUG EFFICACY; FEMALE; HEART LEFT VENTRICLE FILLING PRESSURE; HEMODYNAMICS; HUMAN; MALE; OUTCOME ASSESSMENT; PILOT STUDY; PULMONARY ARTERY OCCLUSION PRESSURE; SHORT COURSE THERAPY; SPONTANEOUS BREATHING; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; CARDIOTONIC AGENTS; DOBUTAMINE; FEMALE; HEMODYNAMICS; HUMANS; HYDRAZONES; MALE; MIDDLE AGED; PILOT PROJECTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY WEDGE PRESSURE; PYRIDAZINES; RESPIRATION; RESPIRATION, ARTIFICIAL; VENTILATOR WEANING; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79551592621     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2010.01.002     Document Type: Article

References (47)

1. Abroug F., Ouanes-Besbes L. Detection of acute heart failure in chronic obstructive pulmonary disease patients: role of B-type natriuretic peptide. Curr Opin Crit Care 2008, 14(3):340-347.
2. Rutten F.H., Cramer M.J., Lammers J.W., et al. Heart failure and chronic obstructive pulmonary disease: an ignored combination?. Eur J Heart Fail 2006, 8(7):706-711.
3. Rutten F.H., Cramer M.J., Zuithoff N.P., et al. Comparison of B-type natriuretic peptide assays for identifying heart failure in stable elderly patients with a clinical diagnosis of chronic obstructive pulmonary disease. Eur J Heart Fail 2007, 9(6-7):651-659.
4. Curkendall S.M., DeLuise C., Jones J.K., et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006, 16(1):63-70.
5. Rutten F.H., Moons K.G., Cramer M.J., et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005, 331(7529):1379.
6. McCullough P., Hollander J., Nowak R., et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 2003, 10(3):198-204.
7. Grasso S., Leone A., De Michele M., et al. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease. Crit Care Med 2007, 35(1):96-105.
8. Abroug F., Ouanes-Besbes L., Nciri N., et al. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers. Am J Respir Crit Care Med 2006, 174(9):990-996.
9. Lemaire F., Teboul J.L., Cinotti L., et al. Acute left ventricular dysfunction during unsuccessful weaning from mechanical ventilation. Anesthesiology 1988, 69(2):171-179.
10. Jubran A., Mathru M., Dries D., et al. Continuous recordings of mixed venous oxygen saturation during weaning from mechanical ventilation and the ramifications thereof. Am J Respir Crit Care Med 1998, 158(6):1763-1769.
11. Richard C., Teboul J.L., Archambaud F., et al. Left ventricular function during weaning of patients with chronic obstructive pulmonary disease. Intensive Care Med 1994, 20(3):181-186.
12. Purro A., Appendini L., De Gaetano A., et al. Physiologic determinants of ventilator dependence in long-term mechanically ventilated patients. Am J Respir Crit Care Med 2000, 161(4 Pt 1):1115-1123.
13. Sterba M., Banerjee A., Mudaliar Y. Prospective observational study of levosimendan and weaning of difficult-to-wean ventilator dependent intensive care patients. Crit Care Resusc 2008, 10(3):182-186.
14. Feihl F., Broccard A.F. Interactions between respiration and systemic hemodynamics. Part II: practical implications in critical care. Intensive Care Med 2009, 35(2):198-205.
15. Richard C., Teboul J.L. Weaning failure from cardiovascular origin. Intensive Care Med 2005, 31(12):1605-1607.
16. Teboul J.L., Richard C. How to diagnose weaning-induced pulmonary edema?. Intensive Care Med 2006, 32(6):938.
17. Chatila W., Ani S., Guaglianone D., et al. Cardiac ischemia during weaning from mechanical ventilation. Chest 1996, 109(6):1577-1583.
18. Upadya A., Tilluckdharry L., Muralidharan V., et al. Fluid balance and weaning outcomes. Intensive Care Med 2005, 31(12):1643-1647.
19. Costanzo M.R., Guglin M.E., Saltzberg M.T., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2007, 49(6):675-683.
20. Dec G.W. Acute decompensated heart failure: the shrinking role of inotropic therapy. J Am Coll Cardiol 2005, 46(1):65-67.
21. Reade M.C. The case for dobutamine. Crit Care Resusc 2008, 10(3):179.
22. Petersen J.W., Felker G.M. Inotropes in the management of acute heart failure. Crit Care Med 2008, 36(1 Suppl):S106-S111.
23. Parissis J.T., Rafouli-Stergiou P., Paraskevaidis I., et al. Levosimendan: from basic science to clinical practice. Heart Fail Rev 2008.
24. Delle Karth G., Buberl A., Geppert A., et al. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines. Acta Anaesthesiol Scand 2003, 47(10):1251-1256.
25. Kivikko M., Lehtonen L., Colucci W.S. Sustained hemodynamic effects of intravenous levosimendan. Circulation 2003, 107(1):81-86.
26. Morelli A., De Castro S., Teboul J.L., et al. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression. Intensive Care Med 2005, 31(5):638-644.
27. Morelli A., Teboul J.L., Maggiore S.M., et al. Effects of levosimendan on right ventricular afterload in patients with acute respiratory distress syndrome: a pilot study. Crit Care Med 2006, 34(9):2287-2293.
28. Kerbaul F., Rondelet B., Demester J.P., et al. Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure. Crit Care Med 2006, 34(11):2814-2819.
29. Meaudre E., Jego C., Goutorbe P., et al. Weaning failure from mechanical ventilation due to dilated cardiomyopathy: successful use of levosimendan. Acta Anaesthesiol Scand 2009, 53(3):416-417.
30. Esteban A., Frutos F., Tobin M.J., et al. A comparison of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure Collaborative Group. N Engl J Med 1995, 332(6):345-350.
31. Boussuges A., Blanc P., Molenat F., et al. Evaluation of left ventricular filling pressure by transthoracic Doppler echocardiography in the intensive care unit. Crit Care Med 2002, 30(2):362-367.
32. Bouhemad B., Nicolas-Robin A., Benois A., et al. Echocardiographic Doppler assessment of pulmonary capillary wedge pressure in surgical patients with postoperative circulatory shock and acute lung injury. Anesthesiology 2003, 98(5):1091-1100.
33. Firstenberg M.S., Levine B.D., Garcia M.J., et al. Relationship of echocardiographic indices to pulmonary capillary wedge pressures in healthy volunteers. J Am Coll Cardiol 2000, 36(5):1664-1669.
34. Garcia M.J., Ares M.A., Asher C., et al. An index of early left ventricular filling that combined with pulsed Doppler peak E velocity may estimate capillary wedge pressure. J Am Coll Cardiol 1997, 29(2):448-454.
35. Lamia B., Maizel J., Ochagavia A., et al. Echocardiographic diagnosis of pulmonary artery occlusion pressure elevation during weaning from mechanical ventilation. Crit Care Med 2009, 37(5):1696-1701.
36. Follath F., Cleland J.G., Just H., et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 2002, 360(9328):196-202.
37. Innes C.A., Wagstaff A.J. Levosimendan: a review of its use in the management of acute decompensated heart failure. Drugs 2003, 63(23):2651-2671.
38. Shin D.D., Brandimarte F., De Luca L., et al. Review of current and investigational pharmacologic agents for acute heart failure syndromes. Am J Cardiol 2007, 99(2A):4A-23A.
39. Ukkonen H., Saraste M., Akkila J., et al. Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 2000, 68(5):522-531.
40. Nieminen M.S., Pollesello P., Vajda G., et al. Effects of levosimendan on the energy balance: preclinical and clinical evidence. J Cardiovasc Pharmacol 2009, 53(4):302-310.
41. Sonntag S., Sundberg S., Lehtonen L.A., et al. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. J Am Coll Cardiol 2004, 43(12):2177-2182.
42. Kivikko M., Antila S., Eha J., et al. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure. J Clin Pharmacol 2002, 42(1):43-51.
43. Barraud D., Faivre V., Damy T., et al. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone. Crit Care Med 2007, 35(5):1376-1382.
44. Dernellis J., Panaretou M. Effects of levosimendan on restrictive left ventricular filling in severe heart failure: a combined hemodynamic and Doppler echocardiographic study. Chest 2005, 128(4):2633-2639.
45. Mebazaa A., Nieminen M.S., Packer M., et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 2007, 297(17):1883-1891.
46. Kerbaul F., Gariboldi V., Giorgi R., et al. Effects of levosimendan on acute pulmonary embolism-induced right ventricular failure?. Crit Care Med 2007.
47. Antoniades C., Tousoulis D., Koumallos N., et al. Levosimendan: beyond its simple inotropic effect in heart failure. Pharmacol Ther 2007, 114(2):184-197.